OPTIMIZERX CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.81 USD | -0.92% |
|
+1.79% | -24.46% |
| Apr. 29 | OptimizeRx Corporation Provides Earnings Guidance for the First Quarter of 2024 | CI |
| Apr. 16 | Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2024 * | 101M | Sales 2025 * | 113M | Capitalization | 197M |
|---|---|---|---|---|---|
| Net income 2024 * | -17M | Net income 2025 * | -12M | EV / Sales 2024 * | 1.94 x |
| Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.74 x |
| P/E ratio 2024 * |
-11.6
x | P/E ratio 2025 * |
-20.2
x | Employees | 136 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.69% |
More Fundamentals
* Assessed data
More news
Latest transcript on OptimizeRx Corporation
More recommendations
More press releases
| 1 day | -0.92% | ||
| 1 week | +1.79% | ||
| Current month | +5.98% | ||
| 1 month | +0.46% | ||
| 3 months | -30.44% | ||
| 6 months | +18.53% | ||
| Current year | -24.46% |
1 week
10.42
11.04
1 month
8.4411.04
Current year
8.4416.65
1 year
6.9216.65
3 years
6.9299.18
5 years
6.5099.18
10 years
1.8999.18
| Managers | Title | Age | Since |
|---|---|---|---|
Will Febbo
CEO | Chief Executive Officer | 55 | 16-02-21 |
Edward Stelmakh
DFI | Director of Finance/CFO | 58 | 21-10-10 |
| President | 46 | 19-04-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gregory Wasson
BRD | Director/Board Member | 65 | 20-07-20 |
Catherine Klema
BRD | Director/Board Member | 65 | Jan. 23 |
Patrick Spangler
BRD | Director/Board Member | 68 | 18-03-26 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 10.81 | -0.92% | 129,423 |
| 24-05-09 | 10.91 | +2.92% | 101,402 |
| 24-05-08 | 10.6 | -1.76% | 110,637 |
| 24-05-07 | 10.79 | +1.60% | 72,445 |
| 24-05-06 | 10.62 | 0.00% | 146,957 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotes
OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.
Sector
Internet Services
Calendar
2024-05-13
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
10.81
USD
Average target price
16.17
USD
Spread / Average Target
+49.55%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -24.46% | 197M | |
| +29.02% | 441B | |
| +25.47% | 263B | |
| +8.80% | 140B | |
| +7.48% | 92.89B | |
| +25.85% | 90.53B | |
| +56.78% | 58.64B | |
| +16.13% | 46.96B | |
| +2.85% | 36.7B | |
| +20.84% | 36.11B |
- Stock Market
- Equities
- OPRX Stock